Menu

Phathom Pharmaceuticals, Inc. PHAT

Full chart Compare
Set alert

Price alert · PHAT

All alert types
5.25 USD +0.17 (+3.35%)

At closeNov 6, 2026, 4:20 PM EST

5.25 0.00 0.00%

After hours · Nov 6, 4:20 PM ET

5.04 Day range 5.31
5.08 52-week range 18.08
YTD
-68.35%
1 year
-59.74%

Revenue & Expenses

Revenue → Gross Profit: $152.51MGross Profit → Expenses: $152.51MRevenue → Cost of Revenue: $22.60MExpenses → Selling, General & Admin: $279.72MExpenses → Research & Development: $32.78MExpenses → Other Expenses: $61.26MNet Loss → Expenses: $221.25MGross Profit$152.51MNet Loss$221.25MCost of Revenue$22.60MExpenses$373.76MSelling, General & Admin$279.72MResearch & Development$32.78MOther Expenses$61.26MRevenue$175.11M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

PHAT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
175.11M55.25M682.00K00
175.11M55.25M682.00K00
22.60M7.97M167.00K00
152.51M47.28M515.00K00
312.50M324.75M167.83M172.44M135.08M
32.78M34.08M49.90M71.44M72.34M
279.72M290.66M117.93M101.00M62.74M
-159.99M-277.47M-167.31M-172.44M-135.08M
68.11M72.01M41.97M27.30M6.79M
-221.25M-334.33M-201.59M-197.72M-143.88M
-221.25M-334.33M-201.59M-197.72M-143.88M
-221.25M-334.33M-201.59M-197.72M-143.88M
-221.25M-334.33M-201.59M-197.72M-143.88M
-3.03-5.29-3.93-5.05-3.89
-3.03-5.29-3.93-5.05-3.89
-3.03-5.29-3.93-5.05-3.89
-153.13M-262.32M-159.62M-170.42M-137.09M
-153.13M-262.32M-159.62M-170.42M-137.09M
72.92M63.18M51.29M39.12M37.00M
72.92M63.18M51.29M39.12M37.00M